fbpx

Business Healthcare Innovation Techonomy Events

Building Health+Wealth in America

Now is the time to take an urgent and holistic look at where the country is headed. We think of both “health” and “wealth” in a broad sense­–what will make the nation and its people healthier, and: what should we mean by “wealth” in an age cursed by deep inequality?   More

Healthcare Innovation The Pandemic

Sick Care or Health Care: 10 Post-Covid Expectations for American Healthcare

A major tech-infused healthcare movement has been in the works for more than a decade. COVID just kicked it into high gear. Here are ten things you need to think about.   More

Bio & Life Sciences Healthcare The Pandemic

Five Things Genomics Has Taught Us About COVID-19

‘Everything is unprecedented about the pandemic, and genomics is no exception,’ says an infectious disease expert. Genome sequencing has enabled scientists to track the virus, study its origins, confirm reinfection, and get to know more about it than has been learned about any organism in such a short time.   More

Bio & Life Sciences Healthcare Innovation

Your Camera Knows You’re the Picture of Health–or If You Have COVID

Several companies are developing technology that can read your vital signs (and screen for COVID) via your smartphone camera simply by looking at your face.   More

Bio & Life Sciences Healthcare

Science Association Chief Very Worried about COVID’s Impact on Research

The president of the American Association for the Advancement of Science says the pandemic’s toll on non-COVID science is ‘a huge hit.’. Many research studies shut down midway, possibly turning results into a total loss.   More

Bio & Life Sciences Healthcare

For All Its Promise, Genomic Testing Is Struggling

For both clinical and consumer markets, genomic testing has a lot to offer — but it isn’t always used where it could be valuable, and people don’t understand it well enough. As a result, demand is dwindling in some areas.   More

Bio & Life Sciences Healthcare The Pandemic

A COVID Vaccine? Six Things to Watch

A good COVID-19 vaccine is the game-changer we all want and need. Here are six things to watch as the process unfolds.   More

Bio & Life Sciences Healthcare Science

How America’s Low Science Literacy Fueled the COVID Crisis

Americans have an uneasy relationship with science, and it’s influenced our sorry response to the COVID-19 pandemic. What could we do to improve the situation?   More

Healthcare Innovation

What Does the Surge In Telemedicine Really Mean?

Telemedicine has the promise to improve the customer experience of care and the health of populations, reduce the per capital cost of health care, and improve the experience of providing it. But individual patients will ultimately decide whether the growing benefits of telemedicine outweigh its potential downsides.   More

Healthcare Innovation Leadership Techonomy Events

Techonomy Virtual Day Three: Innovation in Uncertain, Even Scary Times

Topics included marketing amidst Covid, innovations in health care right now, and why 5G wireless will be revolutionary.   More

Bio & Life Sciences Healthcare Mobile

Why Americans Hate Contact Tracing

Americans are about as likely to report they’ve had Covid-19 and turn over their contacts as they are to report they’ve got head lice or STDs.   More

Business Healthcare Innovation

These Tech Nonprofits for Seniors Pivoted Online–With Challenges

Covid-19 has been particularly unkind to older people and has exacerbated what’s been called the Loneliness Epidemic. Now nonprofits are using tech to provide a better quality of life for aging and disabled populations.   More

Community Insights Healthcare Resilience

How Second-Order Effects Will Shape the Post COVID-19 World

As we await a vaccine that may confer widespread immunity, how successfully we collectively address the Second Order Effects of the pandemic will shape our destiny.   More

Bio & Life Sciences Healthcare

Genetic Counselors Embrace Tech to Help More Patients

To meet demand for interpretation of genetic tests, counselors are turning to chatbots, telemedicine, and more. A new grant opportunity from the NIH is another major boost.   More

Bio & Life Sciences Healthcare Internet of Things

Now Every Doctor’s a “Teledoc” But What’s Next?

Before the pandemic less than 10% of the American population had tried telehealth services. Most of us felt telehealth generally wasn’t much more than a doctor-directed self examination.  “Where does it hurt?  Do you have a fever? ”  A typical session via companies like Teladoc, Amwell or HealthTap took 15 minutes and cost something like […]   More

Bio & Life Sciences Healthcare

As We Wait For a Vaccine, Scientists Eye Antibodies

Antibody-based therapies may pave the way out of pandemic lockdown regardless of how soon a vaccine is available. ‘The science has been really blazing fast,’ says one expert.   More

Global Tech Healthcare Resilience

What’s Next for Testing, Tracking, Treatment, and Tech?

As we seek to move to a safer phase of Covid-19 response and remediation around the world, how is tech contributing? Experts in testing, tracking, and treatment joined our roundtable to help Techonomy’s community ground itself in the new realities.   More

CDX Healthcare Innovation Transportation

Hyundai, Gilead Sciences, and Charlene Li on Innovation Now

Our CDX Digital Roundtable series recently welcomed leading innovation experts from Gilead Sciences and Hyundai as well as digital transformation expert and author, Charlene Li. All of them are leveraging external innovation to drive digital business transformation.   More

Healthcare Innovation

In Healthcare, It’s a Virtue to Be Virtual

The United States has some of the world’s best healthcare, but it’s not equally distributed. In fact, it’s designed to be unequally spread. That’s something we need to fix.   More

Design Healthcare Innovation

Inspired at CES, Seattle Teenagers Tackle Tech to Diagnose Covid-19

At ages 15 and 16 respectively, Sage Khanuja and Nikolas Ioannou were among five winners of Young Innovators to Watch award at CES in January. Their project, Spria, was a low-cost 3D-printed device that could, when administered with a mobile app survey, detect early signs of COPD. Now, they’re developing a smartphone-based technology to offer clinical-quality testing to assess lung capacity just with a phone alone.   More